Abstract
Purpose
Prior studies reporting efficacy of radiofrequency catheter ablation for complex ventricular ectopy in mitral valve prolapse (MVP) are limited by selective inclusion of bileaflet MVP, papillary muscle only ablation, or short-term follow-up. We sought to evaluate the long-term incidence of hemodynamically significant ventricular tachycardia (VT) or fibrillation (VF) in patients with MVP after initial ablation.
Methods
We studied consecutive patients with MVP undergoing ablation for complex ventricular ectopy between 2013 and 2017 at our institution. Of 580 patients with MVP, we included 15 (2.6%, 10 women; mean age 50 ± 14 years, 53% bileaflet) with complex ventricular ectopy treated with initial ablation.
Results
Over a median follow-up of 3406 (1875-6551) days or 9 years, 5 of 15 (33%) patients developed hemodynamically significant VT/VF after their initial ablation and underwent placement of an implantable cardioverter defibrillator (ICD). Three of 5 also underwent repeat ablations. Sustained VT was inducible prior to index ablation in all 5 who developed VT/VF, compared to none of the 10 patients who did not develop VT/VF after index ablation (p = 0.002). Complex ventricular ectopy at index ablation was multifocal in all 5 patients who underwent repeat intervention versus 4 of 10 patients (40%) who did not (p = 0.04). All 3 patients with subsequent VT/VF who underwent repeat ablation had a new clinically dominant focus of ventricular arrhythmia and 3 of the patients with ICD had appropriate VT/VF therapies.
Conclusions
In the long term, a subset of MVP patients treated with ablation for ventricular arrhythmias, all with multifocal ectopy on initial EP study, develop hemodynamically significant VT/VF. Our findings suggest the progressive nature of ventricular arrhythmias in patients with MVP and multifocal ectopy.
Similar content being viewed by others
Availability of data
Data are available upon reasonable request.
References
Narayanan K, Uy-Evanado A, Teodorescu C, Reinier K, Nichols GA, Gunson K, et al. Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm. 2016;13(2):498–503. https://doi.org/10.1016/j.hrthm.2015.09.026.
Basso C, Marra MP, Rizzo S, Lazzari MD, Giorgi B, Cipriani A, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015. https://doi.org/10.1161/CIRCULATIONAHA.115.016291.
Basso C, Iliceto S, Thiene G, Perazzolo Marra M. Mitral valve prolapse, ventricular arrhythmias, and sudden death. Circulation. 2019;140(11):952–64. https://doi.org/10.1161/CIRCULATIONAHA.118.034075.
Düren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol. 1988;11(1):42–7.
Nishimura RA, McGoon MD, Shub C, Miller FA, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med. 1985;313(21):1305–9. https://doi.org/10.1056/NEJM198511213132101.
Grigioni F, Enriquez-Sarano M, Ling LH, Bailey KR, Seward JB, Tajik AJ, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34(7):2078–85.
Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62(3):222–30. https://doi.org/10.1016/j.jacc.2013.02.060.
Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 1971;44(1):130–42. https://doi.org/10.1161/01.cir.44.1.130.
Syed FF, Ackerman MJ, McLeod CJ, Kapa S, Mulpuru SK, Sriram CS, et al. Sites of successful ventricular fibrillation ablation in bileaflet mitral valve prolapse syndrome. Circ Arrhythm Electrophysiol. 2016;9(5). https://doi.org/10.1161/CIRCEP.116.004005.
Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. J Am Coll Cardiol Img. 2008;1(3):294–303. https://doi.org/10.1016/j.jcmg.2008.01.013.
Perazzolo Marra M, Basso C, De Lazzari M, Rizzo S, Cipriani A, Giorgi B, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016;9(8):e005030. https://doi.org/10.1161/CIRCIMAGING.116.005030.
Dejgaard LA, Skjølsvik ET, Lie ØH, Ribe M, Stokke MK, Hegbom F, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72(14):1600–9. https://doi.org/10.1016/j.jacc.2018.07.070.
Bumgarner JM, Patel D, Kumar A, Clevenger JR, Trulock KM, Popović Z, et al. Management and outcomes in MVP with ventricular arrhythmias (VAs) undergoing ablation and/or implantation of ICDs. Pacing Clin Electrophysiol. 2019;42:447–52. https://doi.org/10.1111/pace.13613.
Bui AH, Roujol S, Foppa M, Kissinger KV, Goddu B, Hauser TH, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart. 2017;103(3):204–9. https://doi.org/10.1136/heartjnl-2016-309303.
Garbi M, Lancellotti P, Sheppard MN. Mitral valve and left ventricular features in malignant mitral valve prolapse. Open Heart. 2018;5(2):e000925. https://doi.org/10.1136/openhrt-2018-000925.
Lee A, Hamilton-Craig C, Denman R, Haqqani HM. Catheter ablation of papillary muscle arrhythmias: implications of mitral valve prolapse and systolic dysfunction. Pacing Clin Electrophysiol. 2018;41:750–8. https://doi.org/10.1111/pace.13363.
Enriquez A, Shirai Y, Huang J, Liang J, Briceño D, Hayashi T, et al. Papillary muscle ventricular arrhythmias in patients with arrhythmic mitral valve prolapse: electrophysiologic substrate and catheter ablation outcomes. J Cardiovasc Electrophysiol. 2019;30(6):827–35. https://doi.org/10.1111/jce.13900.
Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988;11(5):1010–9.
Delling FN, Vasan RS. Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation. 2014;129(21):2158–70. https://doi.org/10.1161/CIRCULATIONAHA.113.006702.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
Eriksson MJ, Bitkover CY, Omran AS, David TE, Ivanov J, Ali MJ, et al. Mitral annular disjunction in advanced myxomatous mitral valve disease: echocardiographic detection and surgical correction. J Am Soc Echocardiogr. 2005;18(10):1014–22. https://doi.org/10.1016/j.echo.2005.06.013.
Abouezzeddine O, Suleiman M, Buescher T, Kapa S, Friedman PA, Jahangir A, et al. Relevance of endocavitary structures in ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2010;21(3):245–54. https://doi.org/10.1111/j.1540-8167.2009.01621.x.
Hong-Tao Y, Yang M, Zhong L, Lee Y-H, Vaidya VR, Asirvatham SJ, et al. Ventricular premature contraction associated with mitral valve prolapse. Int J Cardiol. 2016;221:1144–9. https://doi.org/10.1016/j.ijcard.2016.06.252.
Slavich M, Palmisano A, Pannone L, Agricola E, Margonato A, Esposito A. Hidden danger behind the prolapse. Circ Cardiovasc Imaging. 2019;12(10):e009639. https://doi.org/10.1161/CIRCIMAGING.119.009639.
Bains S, Tester DJ, Asirvatham SJ, Noseworthy PA, Ackerman MJ, Giudicessi JR. A novel truncating variant in FLNC-encoded Filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome. Mayo Clin Proc. 2019;94(5):906–13. https://doi.org/10.1016/j.mayocp.2018.11.028.
Naksuk N, Syed FF, Krittanawong C, Anderson MJ, Ebrille E, DeSimone CV, et al. The effect of mitral valve surgery on ventricular arrhythmia in patients with bileaflet mitral valve prolapse. Indian Pacing Electrophysiol J. 2016;16(6):187–91. https://doi.org/10.1016/j.ipej.2016.10.009.
Vaidya VR, DeSimone CV, Damle N, Naksuk N, Syed FF, Ackerman MJ, et al. Reduction in malignant ventricular arrhythmia and appropriate shocks following surgical correction of bileaflet mitral valve prolapse. J Interv Card Electrophysiol. 2016;46(2):137–43. https://doi.org/10.1007/s10840-015-0090-5.
Funding
This work was completed with the use of funding provided by National Heart, Lung and Blood Institute R03HL145238 (FND). This source of funding had no role in study design, collection, analysis, interpretation of data, the writing of the report, or the decision to submit for publication.
Author information
Authors and Affiliations
Contributions
The authors contributed to this manuscript through conception and design of study (FND, PM), analysis and interpretation of data (PM, GN, FND), drafting of the manuscript (PM, FND), and collection of the data and critical revision of the manuscript for important intellectual content (LJL, JMS, RA, NB, EPG, ZHT, GMM).
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethical approval
This retrospective study was approved by the University of California, San Francisco’s Institutional Review Board.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Declarations
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 19 kb)
Rights and permissions
About this article
Cite this article
Marano, P.J., Lim, L.J., Sanchez, J.M. et al. Long-term outcomes of ablation for ventricular arrhythmias in mitral valve prolapse. J Interv Card Electrophysiol 61, 145–154 (2021). https://doi.org/10.1007/s10840-020-00775-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-020-00775-1